183 related articles for article (PubMed ID: 10450508)
1. Dissecting the role of CD4+ T cells in autoimmune diabetes through the use of TCR transgenic mice.
Suri A; Katz JD
Immunol Rev; 1999 Jun; 169():55-65. PubMed ID: 10450508
[TBL] [Abstract][Full Text] [Related]
2. Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions.
Graser RT; DiLorenzo TP; Wang F; Christianson GJ; Chapman HD; Roopenian DC; Nathenson SG; Serreze DV
J Immunol; 2000 Apr; 164(7):3913-8. PubMed ID: 10725754
[TBL] [Abstract][Full Text] [Related]
3. MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo.
Kupfer TM; Crawford ML; Pham K; Gill RG
J Immunol; 2005 Aug; 175(4):2309-16. PubMed ID: 16081800
[TBL] [Abstract][Full Text] [Related]
4. Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM.
von Herrath M; Holz A
J Autoimmun; 1997 Jun; 10(3):231-8. PubMed ID: 9218748
[TBL] [Abstract][Full Text] [Related]
5. Cellular and molecular mechanisms for the initiation and progression of beta cell destruction resulting from the collaboration between macrophages and T cells.
Yoon JW; Jun HS; Santamaria P
Autoimmunity; 1998; 27(2):109-22. PubMed ID: 9583742
[TBL] [Abstract][Full Text] [Related]
6. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse.
Goldrath AW; Barber L; Chen KE; Alters SE
J Autoimmun; 1995 Apr; 8(2):209-20. PubMed ID: 7612149
[TBL] [Abstract][Full Text] [Related]
7. Genetic and immunological basis of autoimmune diabetes in the NOD mouse.
Yoshida K; Kikutani H
Rev Immunogenet; 2000; 2(1):140-6. PubMed ID: 11324686
[TBL] [Abstract][Full Text] [Related]
8. Two genetic loci regulate T cell-dependent islet inflammation and drive autoimmune diabetes pathogenesis.
Fox CJ; Paterson AD; Mortin-Toth SM; Danska JS
Am J Hum Genet; 2000 Jul; 67(1):67-81. PubMed ID: 10848492
[TBL] [Abstract][Full Text] [Related]
9. alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.
Hammond KJ; Poulton LD; Palmisano LJ; Silveira PA; Godfrey DI; Baxter AG
J Exp Med; 1998 Apr; 187(7):1047-56. PubMed ID: 9529321
[TBL] [Abstract][Full Text] [Related]
10. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma.
Trembleau S; Penna G; Gregori S; Giarratana N; Adorini L
J Immunol; 2003 Jun; 170(11):5491-501. PubMed ID: 12759426
[TBL] [Abstract][Full Text] [Related]
11. Independent genetic regulation of T-cell and antigen-presenting cell participation in autoimmune islet inflammation.
Fox CJ; Danska JS
Diabetes; 1998 Mar; 47(3):331-8. PubMed ID: 9519736
[TBL] [Abstract][Full Text] [Related]
12. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant.
Kanagawa O; Vaupel BA; Xu G; Unanue ER; Katz JD
J Immunol; 1998 Nov; 161(9):4489-92. PubMed ID: 9794372
[TBL] [Abstract][Full Text] [Related]
13. Beta cell apoptosis in T cell-mediated autoimmune diabetes.
Kurrer MO; Pakala SV; Hanson HL; Katz JD
Proc Natl Acad Sci U S A; 1997 Jan; 94(1):213-8. PubMed ID: 8990188
[TBL] [Abstract][Full Text] [Related]
14. Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus.
Yoon JW; Jun HS
Ann N Y Acad Sci; 2001 Apr; 928():200-11. PubMed ID: 11795511
[TBL] [Abstract][Full Text] [Related]
15. Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction.
Chong MM; Chen Y; Darwiche R; Dudek NL; Irawaty W; Santamaria P; Allison J; Kay TW; Thomas HE
J Immunol; 2004 May; 172(9):5714-21. PubMed ID: 15100317
[TBL] [Abstract][Full Text] [Related]
16. T-bet-deficient NOD mice are protected from diabetes due to defects in both T cell and innate immune system function.
Esensten JH; Lee MR; Glimcher LH; Bluestone JA
J Immunol; 2009 Jul; 183(1):75-82. PubMed ID: 19535634
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune disorders in diabetes.
Boitard C; Debray-Sachs M; Bach JF
Adv Nephrol Necker Hosp; 1986; 15():281-305. PubMed ID: 3082114
[TBL] [Abstract][Full Text] [Related]
18. Prevention of diabetes in non-obese diabetic I-Ak transgenic mice.
Slattery RM; Kjer-Nielsen L; Allison J; Charlton B; Mandel TE; Miller JF
Nature; 1990 Jun; 345(6277):724-6. PubMed ID: 1972779
[TBL] [Abstract][Full Text] [Related]
19. The pathogenicity of islet-infiltrating lymphocytes in the non-obese diabetic (NOD) mouse.
Ablamunits V; Elias D; Cohen IR
Clin Exp Immunol; 1999 Feb; 115(2):260-7. PubMed ID: 9933451
[TBL] [Abstract][Full Text] [Related]
20. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.
Cameron MJ; Arreaza GA; Zucker P; Chensue SW; Strieter RM; Chakrabarti S; Delovitch TL
J Immunol; 1997 Nov; 159(10):4686-92. PubMed ID: 9366391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
